These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 22868184

  • 1. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Testai FD.
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):894. PubMed ID: 22868184
    [No Abstract] [Full Text] [Related]

  • 2. Response to the letter by Lee et al.
    Lee V, Conners JJ, Prabhakaran S.
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):894. PubMed ID: 22902145
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Lee VH, Conners JJ, Prabhakaran S.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):916.e11-2. PubMed ID: 22608344
    [Abstract] [Full Text] [Related]

  • 4. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
    Sangha N, El Khoury R, Misra V, Lopez G.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
    [Abstract] [Full Text] [Related]

  • 5. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M, Szkotak A, Witt A, Shuaib A, Butcher K.
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [Abstract] [Full Text] [Related]

  • 6. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
    De Smedt A, De Raedt S, Nieboer K, De Keyser J, Brouns R.
    Cerebrovasc Dis; 2010 Jul; 30(5):533-4. PubMed ID: 20881383
    [No Abstract] [Full Text] [Related]

  • 7. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC, Marrone AC.
    Cerebrovasc Dis; 2012 Jul; 34(3):246-7. PubMed ID: 23018342
    [No Abstract] [Full Text] [Related]

  • 8. Dabigatran and thrombolysis: A therapeutic dilemma.
    Govindarajan R, Salgado E.
    Ann Neurol; 2012 Oct; 72(4):625; author reply 625-6. PubMed ID: 23109156
    [No Abstract] [Full Text] [Related]

  • 9. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C, Duarte J, Sobral S, Pestana P, Nzwalo H, Rita H, Sousa E Costa J.
    Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
    [Abstract] [Full Text] [Related]

  • 10. Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
    Alvarez Bravo G, Orts Castro E, Carvalho Monteiro G, López Zuazo I.
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):e192-e193. PubMed ID: 28663010
    [Abstract] [Full Text] [Related]

  • 11. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A, Varga V, Béres-Molnár KA, Vadasdi K, Bereczki D.
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
    [Abstract] [Full Text] [Related]

  • 12. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S, Wada K, Nagatani K, Otani N, Osada H, Nawashiro H.
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract] [Full Text] [Related]

  • 13. What if a patient with atrial fibrillation and anticoagulant treatment is suffering from acute ischemia stroke?
    Zhou C, Zhu L, Wu J, Fang S.
    Cerebrovasc Dis; 2013 Jan; 35(1):89-90. PubMed ID: 23429002
    [No Abstract] [Full Text] [Related]

  • 14. Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?
    Pollack CV, Levy JH, Eikelboom J, Weitz JI, Sellke FW, Huisman MV, Steiner T, Kamphuisen P, Bernstein RA.
    Am J Emerg Med; 2014 Nov; 32(11):1433-4. PubMed ID: 25239691
    [No Abstract] [Full Text] [Related]

  • 15. [Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment-a case report and review of literature].
    Inaishi J, Nogawa S, Mano Y, Yoshizaki T, Okada S.
    Rinsho Shinkeigaku; 2014 Nov; 54(3):238-40. PubMed ID: 24705841
    [Abstract] [Full Text] [Related]

  • 16. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
    Casado Naranjo I, Portilla-Cuenca JC, Jiménez Caballero PE, Calle Escobar ML, Romero Sevilla RM.
    Cerebrovasc Dis; 2011 Nov; 32(6):614-5. PubMed ID: 22133608
    [No Abstract] [Full Text] [Related]

  • 17. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C.
    Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
    [Abstract] [Full Text] [Related]

  • 18. Fatal multiple systemic emboli after intravenous thrombolysis for cardioembolic stroke.
    Tanaka K, Ohara T, Ishigami A, Ikeda Y, Matsushige T, Satow T, Ishibashi-Ueda H, Iihara K, Toyoda K.
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):395-7. PubMed ID: 23545321
    [Abstract] [Full Text] [Related]

  • 19. New oral anticoagulants in heart failure.
    Van Gelder IC, Van Veldhuisen DJ, Lip GY.
    Eur J Heart Fail; 2013 Sep; 15(9):966-73. PubMed ID: 23960085
    [No Abstract] [Full Text] [Related]

  • 20. Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Berg AM.
    Ann Intern Med; 2011 Apr 19; 154(8):570; author reply 570-1. PubMed ID: 21502659
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.